Legal Opinion
In Re Ampicillin Antitrust Litigation
United States Judicial Panel on Multidistrict Litigation
Decided July 22, 1970No. Docket 50PublishedCited by 5 opinions
1Opinion of the Court
OPINION AND ORDER
2Per curiam
On March 19, 1970 the United States filed a civil action in the United States District Court for the District of Columbia against Bristol-Myers Company, Beecham Group Limited, and Beecham, Inc. charging them with violations of the Antitrust Laws with respect to ampicillin and other semi-synthetic penicillin drugs. The Government’s complaint alleges that the defendants, in violation of Sections 1 and 2 of the Sherman Act, combined and conspired in unreasonable restraint of trade in these drugs and monopolized trade in ampicillin by fraudulently procuring and enforcing…
3Cases cited4 opinions
- In Re Mid-Air Collision Near Fairland, IndianaUnited States Judicial Panel on Multidistrict Litigation · 1970
- In Re Multidistrict Patent & Antitrust Litigation Involving KoratronUnited States Judicial Panel on Multidistrict Litigation · 1969
- In Re Multidistrict Private Civil Treble Damage Litigation Involving Motor Vehicle Air Pollution Control EquipmentUnited States Judicial Panel on Multidistrict Litigation · 1970
- United States v. PfizerUnited States Judicial Panel on Multidistrict Litigation · 1970
4Cited by5 opinions
- Alpine Pharmacy, Inc., an Illinois Corporation v. Chas. Pfizer & Co., Inc., and Cotler Drugs, Inc.Court of Appeals for the Second Circuit · 1973
- In re Ampicillin Antitrust LitigationDistrict Court, District of Columbia · 1972
- In Re Toilet Seat Antitrust LitigationUnited States Judicial Panel on Multidistrict Litigation · 1975
- In Re Mutual Fund Sales Antitrust LitigationUnited States Judicial Panel on Multidistrict Litigation · 1973
- In re Amoxicillin Patent & Antitrust LitigationUnited States Judicial Panel on Multidistrict Litigation · 1978